Table 3.
Baseline | 4 weeks | 8 weeks | P value | |
---|---|---|---|---|
SBP (mmHg) | ||||
Amlodipine group (n = 60) | 149.66 ± 10.93 | 139.22 ± 9.60 | 131.66 ± 6.40 | <0.0001 |
(140-160) | (130-150) | (125-142) | ||
Lisinopril group (n = 60) | 151 ± 11.86 | 138 ± 7.52 | 132.22 ± 7.76 | <0.0001 |
(142-160) | (132-150) | (125-140) | ||
P < 0.524 | P = 0.444 | P = 0.669 | ||
DBP (mmHg) | ||||
Amlodipine group (n = 60) | 94.69 ± 4.27 | 87.89 ± 3.64 | 84 ± 2.45 | <0.0001 |
(90-100) | (80-92) | (82-90) | ||
Lisinopril group (n = 60) | 95.63 ± 4.87 | 90 ± 2.46 | 85.22 ± 3.23 | <0.0001 |
(90-100) | (80-92) | (84-92) | ||
P = 0.267 | P = 0.0003 | P = 0.025 | ||
MAP (mmHg) | ||||
Amlodipine group (n = 60) | 113.01 ± 4.38 | 104.93 ± 3.12 | 98.89 ± 1.75 | <0.0001 |
(106.67-120) | (96.67-111.30) | 96.33-107.33) | ||
Lisinopril group (n = 60) | 114.13 ± 7.11 | 106.52 ± 3.50 | 100.89 ± 2.80 | <0.0001 |
(107.33-120) | (97.33-113.33) | (97.66-108) | ||
P = 0.305 | P = 0.01 | P = 0.0000 |
Data expressed as mean ± SD; Figures in parentheses indicate range